Page last updated: 2024-10-27

fluconazole and Diathesis

fluconazole has been researched along with Diathesis in 20 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"Systemic Candida infections are a major cause of infectious morbidity and mortality during chemotherapy-induced neutropenia."7.77The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia. ( Wingard, JR, 1992)
"In sequential clinical trials of treatment for histoplasmosis in patients with acquired immunodeficiency syndrome, therapy with fluconazole failed in a higher proportion of patients than did therapy with itraconazole."7.71Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. ( Brizendine, E; Connolly, P; Hafner, R; Smedema, M; Wheat, LJ, 2001)
"Fluconazole alone was not found significantly effective against C."5.32Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole. ( Jabeen, R; Khan, MA; Mohammad, O, 2004)
" Although fluconazole use has been considered one of the main causes for the epidemiologic change in invasive candidiasis, especially in the increase of species less sensitive to this agent, this association remains unproven."4.84[Current treatment of candidemia. Role of anidulafungin]. ( Almirante, B; Pemán, J, 2008)
" On the basis of antifungal susceptibility profile of the isolates, caspofungin can be suggested as a useful antifungal drug for the treatment of candidemia due to fluconazole resistant species."3.83Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections. ( Deorukhkar, SC; Saini, S, 2016)
"Systemic Candida infections are a major cause of infectious morbidity and mortality during chemotherapy-induced neutropenia."3.77The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia. ( Wingard, JR, 1992)
"In sequential clinical trials of treatment for histoplasmosis in patients with acquired immunodeficiency syndrome, therapy with fluconazole failed in a higher proportion of patients than did therapy with itraconazole."3.71Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. ( Brizendine, E; Connolly, P; Hafner, R; Smedema, M; Wheat, LJ, 2001)
"Prior use of fluconazole, severe respiratory failure and hospitalization time are associated with IPA in patients with chronic pneumopathies with respiratory isolation of Aspergillus spp."1.38[Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp]. ( Casal, M; Castón, JJ; Linares, MJ; Rivero, A; Torre-Cisneros, J, 2012)
"Mucormycosis was diagnosed in the neutropenic state following allogeneic hematopoietic cell transplantation (n=3) or intense chemotherapy (n=3)."1.33Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. ( Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G, 2005)
"Fluconazole alone was not found significantly effective against C."1.32Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole. ( Jabeen, R; Khan, MA; Mohammad, O, 2004)

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (15.00)18.2507
2000's10 (50.00)29.6817
2010's6 (30.00)24.3611
2020's1 (5.00)2.80

Authors

AuthorsStudies
Dimopoulos, G1
Velegraki, A1
Falagas, ME1
Amanati, A1
Badiee, P1
Jafarian, H1
Ghasemi, F1
Nematolahi, S1
Haghpanah, S1
Hamzavi, SS1
Altintop, YA1
Ergul, AB1
Koc, AN1
Atalay, MA1
Hernández-Torres, A1
García-Vázquez, E1
Laso-Ortiz, A1
Herrero-Martínez, JA1
Gómez-Gómez, J1
Takaoka, K1
Nannya, Y1
Shinohara, A1
Arai, S1
Nakamura, F1
Kurokawa, M1
Deorukhkar, SC1
Saini, S1
Almirante, B1
Pemán, J1
Chandran, SK1
Lyons, KM1
Divi, V1
Geyer, M1
Sataloff, RT1
Takakura, S1
Castón, JJ1
Linares, MJ1
Rivero, A1
Casal, M1
Torre-Cisneros, J1
Fonseca, EM1
Nuño, FJ1
García-Alcalde, ML1
Menéndez, MJ1
Ozçelik, B1
Citak, S1
Cesur, S1
Abbasoğlu, U1
Içli, F1
Khan, MA1
Jabeen, R1
Mohammad, O1
Bethge, WA1
Schmalzing, M1
Stuhler, G1
Schumacher, U1
Kröber, SM1
Horger, M1
Einsele, H1
Kanz, L1
Hebart, H1
Girmenia, C1
Martino, P1
Cassone, A1
Klepser, ME1
Lewis, RE1
Pfaller, MA1
Trenschel, R1
Peceny, R1
Runde, V1
Elmaagacli, A1
Dermoumi, H1
Heintschel von Heinegg, E1
Müller, KD1
Schaefer, UW1
Beelen, DW1
Wheat, LJ1
Connolly, P1
Smedema, M1
Brizendine, E1
Hafner, R1
Morey, A1
Lima, C1
Matas, B1
Munar, MA1
Wingard, JR1

Reviews

5 reviews available for fluconazole and Diathesis

ArticleYear
[Candida sp endocarditis. Experience in a third-level hospital and review of the literature].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2013, Volume: 26, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacteria

2013
[Current treatment of candidemia. Role of anidulafungin].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14

    Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Disease Suscep

2008
[Candidosis].
    Medical mycology journal, 2011, Volume: 52, Issue:1

    Topics: Antifungal Agents; Candidiasis; Catheters; Contraindications; Cross Infection; Disease Susceptibilit

2011
Therapy of Candida infections: susceptibility testing, resistance, and therapeutic options.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:12

    Topics: Antifungal Agents; Candida; Candidiasis; Disease Susceptibility; Drug Resistance, Microbial; Drug Th

1998
The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
    Leukemia & lymphoma, 1992, Volume: 8, Issue:4-5

    Topics: Amphotericin B; Bone Marrow Transplantation; Candidiasis; Disease Susceptibility; Double-Blind Metho

1992

Trials

2 trials available for fluconazole and Diathesis

ArticleYear
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Bone marrow transplantation, 2000, Volume: 26, Issue:9

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis;

2000
The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
    Leukemia & lymphoma, 1992, Volume: 8, Issue:4-5

    Topics: Amphotericin B; Bone Marrow Transplantation; Candidiasis; Disease Susceptibility; Double-Blind Metho

1992

Other Studies

14 other studies available for fluconazole and Diathesis

ArticleYear
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; In

2009
Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy.
    Scientific reports, 2021, 07-08, Volume: 11, Issue:1

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Antimicrobial Stewardship; Candida; Caspofungin; Chil

2021
Evaluation of Candida colonization and use of the Candida Colonization Index in a paediatric Intensive Care Unit: a prospective observational study.
    Le infezioni in medicina, 2019, Jun-01, Volume: 27, Issue:2

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Child; Child, Presc

2019
A novel scoring system to predict the incidence of invasive fungal disease in salvage chemotherapies for malignant lymphoma.
    Annals of hematology, 2014, Volume: 93, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; C

2014
Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections.
    Infectious disorders drug targets, 2016, Volume: 16, Issue:1

    Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidemia; Candidiasis, Invasive; C

2016
Fungal laryngitis.
    Ear, nose, & throat journal, 2009, Volume: 88, Issue:8

    Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Antifungal Agents; Candidiasis; Disease Suscept

2009
[Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp].
    Medicina clinica, 2012, Dec-15, Volume: 139, Issue:15

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Asthma; Bacterial Infections; Carrier State

2012
[Infection due to herpes zoster and cryptococcus after initiating high-activity antiretroviral treatment].
    Enfermedades infecciosas y microbiologia clinica, 2003, Volume: 21, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents;

2003
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
    Drug metabolism and drug interactions, 2004, Volume: 20, Issue:1-2

    Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans

2004
Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole.
    Pharmaceutical research, 2004, Volume: 21, Issue:12

    Topics: Animals; Cell Line; Chloroquine; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Di

2004
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
    Haematologica, 2005, Volume: 90 Suppl

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emergi

2005
Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies.
    Blood, 1996, Jan-15, Volume: 87, Issue:2

    Topics: Candida; Candidiasis; Catheterization, Central Venous; Disease Susceptibility; Drug Resistance, Micr

1996
Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Dec-01, Volume: 33, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Diseas

2001
[Fluconazole prophylaxis for fungal peritonitis in peritoneal dialysis].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2001, Volume: 21, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Diabetic Nephropathies;

2001